Editorial & Advertiser disclosure

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Investing

Posted By Jessica Weisman-Pitts

Posted on December 4, 2024

UK’s FTSE 100 falls as AstraZeneca, BoE Governor’s remarks weigh

(Reuters) – The UK’s benchmark FTSE 100 fell on Wednesday, ending a five-day winning streak, dragged by AstraZeneca’s decline on target price cut, while investors assessed domestic economic data and Bank of England Governor’s Andrew Bailey remarks on interest rate cuts.

The blue-chip FTSE 100 fell 0.3%, while the midcap FTSE 250 rose 0.2% to hit more than a six-week high at 1012 GMT.

AstraZeneca slipped 2.7% to the bottom of the blue-chip index after HSBC analysts cut the target price on the drugmaker’s stock to 13,720p from 14,070p.

BoE’s Bailey reiterated that there will be gradual cuts in interest rates next year, adding that the process of falling inflation is well embedded.

The BoE is expected to keep interest rates on hold at 4.75% this month, but deliver about 78 basis points worth of rate cut by the end of next year.

The sterling fell after the Financial Times reported Bailey saying the BoE expected four interest rate cuts next year.

Shares of miners Antofagasta, Glencore and Anglo American declined between 0.9% and 1.7% with copper prices easing against a firm dollar. [MET/L]

Additionally, ZIGUP was the top loser on the midcap index, falling 8.4% as the commercial vehicle rental provider’s pretax profit fell 17.2% to 82 million pounds ($104.1 million) for the first half.

Legal & General was a standout and gained 3.4% as the life insurer said it anticipates returning to shareholders a proportion of capital this year and was on track to deliver mid-single digit growth in operating profit for the financial year 2024.

Meanwhile, Britain’s dominant services sector lost steam in November, although not as much as first feared, as a looming rise in employer taxes weighed on firms’ hiring plans, a survey showed.

On the global front, investors braced for a crucial no-confidence vote by French lawmakers that will likely oust Prime Minister Michel Barnier’s government. France’s benchmark index CAC 40 was up 0.2%.

(This story has been corrected to say ‘six-week high,’ not ‘seven-week high,’ in paragraph 2)

(Reporting by Nikhil Sharma in Bengaluru; Editing by Shinjini Ganguli)

Recommended for you

  • UK’s FTSE 100 logs biggest weekly gain in 5 weeks

  • UK’s FTSE 100 little changed after holiday break; indexes set for weekly gains

  • European shares crawl higher to one-week high on tech boost